(Q46573430)

23 December 2017

title

Antidepressant-like effects of agomelatine, melatonin and the NK1 receptor antagonist GR205171 in impulsive-related behaviour in rats (English)

1 reference

23 December 2017

0 references

Florence Loiseau

1

1 reference

23 December 2017

Claudine Le Bihan

series ordinal

2

1 reference

23 December 2017

Michel Hamon

series ordinal

3

1 reference

23 December 2017

Marie-Hélène Thiébot

series ordinal

4

1 reference

23 December 2017

publication date

29 September 2005

1 reference

23 December 2017

published in

Psychopharmacology

1 reference

23 December 2017

volume

182

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

24-32

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-005-0050-3

exact match

0 references

cites work

Norepinephrine function in personality disorder: plasma free MHPG correlates inversely with life history of aggression

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-005-0050-3

Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-005-0050-3

The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-005-0050-3

Melatonin or a melatonin agonist corrects age-related changes in circadian response to environmental stimulus

21 January 2018

1 reference

12 December 2020

Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats

1 reference

12 December 2020

Central nervous system depressant activities of melatonin in rats and mice

1 reference

12 December 2020

GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity

1 reference

12 December 2020

Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression

1 reference

12 December 2020

Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.

1 reference

12 December 2020

Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects

1 reference

12 December 2020

Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation

1 reference

12 December 2020

Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study

1 reference

12 December 2020

Melatonin MT(1/2) receptor stimulation reduces cortical overflow of cholecystokinin-like material in a model of anticipation of social defeat in the rat.

1 reference

12 December 2020

Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse

1 reference

12 December 2020

Melatonin enhancement of [3H]-gamma-aminobutyric acid and [3H]muscimol binding in rat brain

1 reference

12 December 2020

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

12 December 2020

Effect of central 5-hydroxytryptamine depletion on tolerance of delay of reinforcement: evidence from performance in a discrete-trials "time-left" procedure

1 reference

12 December 2020

Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats.

1 reference

12 December 2020

Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat.

1 reference

12 December 2020

Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade

1 reference

12 December 2020

Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils.

1 reference

12 December 2020

Acute antidepressant-like and antianxiety-like effects of tryptophan in mice

1 reference

12 December 2020

Pharmacological effects of melatonin treatment on both locomotor activity and brain serotonin release in rats

1 reference

12 December 2020

Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward in rats. Possible implication in the behavioral mechanism of action of antidepressants

1 reference

12 December 2020

Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated

1 reference

12 December 2020

Effect of neurokinin-I receptor antagonists on the function of 5-HT and noradrenaline neurons

1 reference

12 December 2020

Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function

1 reference

12 December 2020

Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats.

1 reference

12 December 2020

Is delay of reward mediated by shock-avoidance behavior a critical target for anti-punishment effects of diazepam in rats?

1 reference

12 December 2020

Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats

1 reference

12 December 2020

Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway.

1 reference

12 December 2020

The effect of nifedipine, Ca(2+) antagonist, on activity of MAO inhibitors, N-acetylserotonin and melatonin in the mouse tail suspension test

1 reference

12 December 2020

Clomipramine and exposure for obsessive-compulsive rituals: i

1 reference

12 December 2020

The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism

1 reference

12 December 2020

5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion

1 reference

12 December 2020

Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders

1 reference

12 December 2020

Fluoxetine treatment of obsessive-compulsive disorder

1 reference

12 December 2020

The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists

1 reference

12 December 2020

Effect of agomelatine in the chronic mild stress model of depression in the rat.

1 reference

12 December 2020

The effects of melatonin on the behavioural disturbances induced by chronic mild stress in C3H/He mice.

1 reference

12 December 2020

Changes in serotonin level and turnover in discrete hypothalamic nuclei after pinealectomy and melatonin administration to rats.

1 reference

12 December 2020

Serotonin and tolerance to delay of reward in rats.

1 reference

12 December 2020

Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3.

1 reference

12 December 2020

Effects of single doses and daily melatonin treatments on serotonin metabolism in rat brain regions

1 reference

12 December 2020

New selective ligands of human cloned melatonin MT1 and MT2 receptors.

1 reference

12 December 2020

The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats

1 reference

12 December 2020

Benzodiazepines reduce the tolerance to reward delay in rats

1 reference

12 December 2020

Identification of the melatonin-binding site MT3 as the quinone reductase 2.

1 reference

12 December 2020

Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms.

1 reference

12 December 2020

Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist

1 reference

12 December 2020

Effects of melatonin on neophobic responses in different strains of mice.

1 reference

12 December 2020

Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence

1 reference

12 December 2020

Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response

1 reference

12 December 2020

Anxiolytic-like properties of melatonin receptor agonists in mice: involvement of mt1 and/or MT2 receptors in the regulation of emotional responsiveness

1 reference

12 December 2020

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

1 reference

12 December 2020

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

1 reference

12 December 2020

Effects of combined or separate 5,7-dihydroxytryptamine lesions of the dorsal and median raphe nuclei on responding maintained by a DRL 20s schedule of food reinforcement.

1 reference

12 December 2020

Effects of melatonin receptor ligands on swim test immobility

1 reference

12 December 2020

Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior

1 reference

12 December 2020

10.1007/S00213-005-0050-3

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017